Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

"AHPA requests that a statement about the potential for mislabeling of dietary supplements that contain echinacea, and herbal preparations generally, be removed from the NCCAM website, and that inaccurate statements attributed to you by numerous news media about a recent study on echinacea be corrected," AHPA states in an Oct. 4 communication to NCCAM Director Stephen Straus, MD. The letter addresses Straus' comment: "Preparations of echinacea, like any herb, can be variable - what's on the label may not always be what's in the bottle." The second clause is a "gratuitous criticism of the industry," the trade group says. AHPA also asks NCCAM to clarify recent "erroneous" statements the center made to The New York Times and The Los Angeles Times regarding echinacea dosages. AHPA separately requested that FDA correct statements about supplements in the GMP final rule...

Related Content

NCCAM on echinacea





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts